QUOTIENT SCIENCES LIMITED offer service "Clinical Pharmacology"

Quotient Sciences focuses on Phase I trials and early clinical development, moving molecules from first-in-human studies to proof-of-concept so critical decisions can be made sooner. Every Phase I clinical pharmacology study is delivered as a fully integrated program spanning design, startup, and data reporting, covering study types for special populations, human ADME, regulatory affairs, data sciences, modeling and simulation, gamma scintigraphy, and integrated pharmacy compounding with GMP manufacturing.